| related words |
| dacogen |
| ferumoxytol |
| increlex |
| isolagen |
| pathway |
| dose |
| qnexa |
| essure |
| vantas |
| erbitux |
| pralatrexate |
| dosage |
| premarket |
| visudyne |
| biodefense |
| veridex |
| folotyn |
| diamondback |
| costar |
| zfp |
|
| related documents |
| 722104--3/1/2010--SAVIENT_PHARMACEUTICALS_INC |
|
| related topics |
| {product, liability, claim} |
| {product, candidate, development} |
| {control, financial, internal} |
| {acquisition, growth, future} |
| {personnel, key, retain} |
| {product, market, service} |
| {provision, law, control} |
| {debt, indebtedness, cash} |
| {stock, price, operating} |
| {cost, regulation, environmental} |
| {cost, operation, labor} |
| {customer, product, revenue} |
| {regulation, change, law} |
| {competitive, industry, competition} |
| {interest, director, officer} |
| {property, intellectual, protect} |
| {condition, economic, financial} |
| {gas, price, oil} |
| {stock, price, share} |
| {capital, credit, financial} |
|